Enliven Therapeutics, Inc. (ELVN)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
53. 20
+2.34
+4.6009%
$
3.7B Market Cap
- P/E Ratio
- Div Yield
818,000 Volume
-2.36 Eps
$ 50.86
Previous Close 
Want to track ELVN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ELVN Earnings Reports FAQ
What is the earnings per share (EPS) for ELVN?
The current EPS is -2.36.
What is the company's earnings growth rate?
Enliven Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Enliven Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Enliven Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ELVN at this time, as Enliven Therapeutics, Inc has no recent EPS data to calculate it.
